Loading clinical trials...
Loading clinical trials...
Multi-center, prospective, within-subject control, open label clinical trial to evaluate the durability of the safety and effectiveness of the Eclipse™ System after 3 and 12 months of use.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pelvalon, Inc.
NCT05626816 · Fecal Incontinence
NCT06532123 · Fecal Incontinence
NCT04506593 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), and more
NCT05771597 · Fecal Incontinence, Dyssynergic Defecation, and more
NCT03825575 · Fecal Incontinence
University of Alabama
Birmingham, Alabama
Massachusetts General Hospital (MGH)
Boston, Massachusetts
University of New Mexico
Albuquerque, New Mexico
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions